For example, Chorianopoulos et al. [90] reported that pre- and post-interventional hs-cTnT levels positively correlated with 1-year mortality rates in patients with severe AS, independent of successful aortic valve replacement, while there are numerous controversial data from the clinical setting reflecting the fact that only pre-TAVR hs-cTnT levels predicted all-cause death in these patients [91,92]. This evidence concerns the gene TNNT2 and aortic valve stenosis.